ASX Announcement
BrainChip Granted New US Patent
• Patent US 11,468,299 “An Improved Spiking Neural Network” issued to BrainChip
Sydney – 12 October 2022:
BrainChip Holdings Ltd (“BrainChip” or the “Company”) (ASX: BRN, OTCQX: BRCHF,
ADR: BCHPY),
has issued a US patent for “An Improved Spiking Neural Network”. US 11,468,299 “An Improved Spiking Neural Network” Issuance:
The patent, US 11,468,299, was issued on 11 October 2022 at the US Patents and Trademarks Office (USPTO). The patent is considered by the Company to be a valuable IP asset and increases the patent protection around BrainChip’s unique neuromorphic on-chip learning technology.
Key features of patent:
The patent protects the learning function of BrainChip’s digital neuron circuit implemented on a neuromorphic integrated circuit/system (e.g. AkidaTM).
• The neurons and synapses are implemented efficiently so that a significantly high number of them can be implemented in the most efficient and resource constrained computational environment.
• The memory management of membrane potential values, synapse weights and synapse connections amongst the spiking neuron circuits is handled innovatively, contributing significantly to reducing the power and the cost when delivering edge applications to customers.
• The patent protects a key learning feature when choosing the synapses for weight variation during on-chip learning. The right combination of factors related to accuracy and efficiency is chosen that delivers valuable results during edge learning.
BrainChip’s portfolio now comprises 10 US and 1 Chinese issued patents. In addition, some 27 patent applications are pending in the US, Europe, Australia, Canada, Japan, Korea, India, Brazil, Russia, Mexico, and Israel.
This announcement is authorised for release by the BRN Board of Directors